Table 3

ORs for intermediate markers associated with cigarette and NSAID use

Cigarette useNSAID use
ORa (95% CI)ORa (95% CI)
NeverTertile 1Tertile 2Tertile 3NeverEverFormerCurrent
Histology
 HGD1.01.5 (0.7–3.3)1.4 (0.7–3.2)1.1 (0.5–2.6)1.00.6 (0.4–1.1)0.5 (0.2–1.5)0.7 (0.4–1.2)
Flow cytometry
 Increased 4N1.01.4 (0.5–3.7)1.4 (0.5–3.6)1.1 (0.4–3.2)1.00.7 (0.4–1.5)1.1 (0.4–3.1)0.6 (0.3–1.4)
 Aneuploidy1.01.2 (0.4–3.1)0.4 (0.1–1.4)1.2 (0.5–3.2)1.00.5 (0.2–1.0)0.2 (0.0–1.1)0.6 (0.3–1.3)
Allelic loss
 9p LOH1.01.1 (0.6–2.3)1.3 (0.6–2.6)0.5 (0.2–1.0)1.01.1 (0.6–1.8)0.9 (0.4–2.0)1.1 (0.6–2.0)
 17p LOH1.00.9 (0.4–2.4)1.4 (0.6–3.5)0.9 (0.4–2.3)1.00.4 (0.2–0.8)0.7 (0.3–1.7)0.3 (0.1–0.7)
  • a ORs and 95% CIs adjusted for age, gender, education, waist:hip ratio, BMI, cigarette use, and NSAID use.